Amber heat health alert to come into force as 30C temperatures forecast
The second amber heat health alert in two weeks is set to come into force on Friday, as temperatures are again set to pass 30C this weekend.
The alert, which covers London, the East Midlands, South East, South West and East of England, starts at midday on Friday and will last until 6pm on Tuesday.
The UK Health Security Agency (UKHSA) also issued a yellow alert for Yorkshire and Humber and the West Midlands for the same time period, with the agency warning of significant impacts across health and social care services.
It comes as temperatures could reach 28C on Friday in central and southern England, before rising to 30C on Saturday, then a potential 31C on Sunday, before peaking between 32C and 34C on Monday, the Met Office said.
An amber alert was previously issued for all regions in England on June 19, the first time it had been used since September 2023.
On the same day, temperatures reached 32.2C in Kew, west London, before heatwaves were declared across England and Wales.
An official heatwave is recorded when areas reach a certain temperature for three consecutive days, with thresholds varying from 25C to 28C in different parts of the UK.
Dr Agostinho Sousa, head of extreme events and health protection at the UKHSA, said: 'We have already seen a spell of hot weather last week and temperatures are once again set to increase in the coming days, with central, southern and eastern areas of the country likely to see the biggest impacts.
'Our findings show that heat, especially at the sort of temperatures we are likely to see at the beginning of next week, can result in serious health outcomes across the population, especially for older adults or those with pre-existing health conditions.
'It is, therefore, important to check on friends, family and neighbours who are more vulnerable and to take sensible precautions while enjoying the sun.'
Met Office meteorologist Craig Snell said: 'From Friday onwards we're starting to once again see the heat build across England and Wales.
'Scotland and Northern Ireland are going to have a slightly different few days, some parts of western Scotland could see some heavy rain, especially on Friday, and we could potentially see some further rain towards the end of the weekend.
'On Friday, we're likely to see temperatures potentially peak around 27C or 28C in central and southern parts of England, it's going to feel quite humid.
'On Saturday, the hottest weather will be in the south east, potentially 30C.
'On Sunday, we're most likely to see somewhere around 30C or 31C.
'It looks like the peak of the hot spell will be Monday, at the moment it's looking between 32C and 34C, there's a chance it'll be hotter than the previous (heatwave).
'Tuesday, some fresher air is going to spread across the country, but we're potentially likely to see between 31C and 33C.'
Some parts of central and southern England might meet the heatwave criteria by Monday, Mr Snell added.
As of Monday, some potential thunderstorms could move in, but it is too early to say where they might be, he said.
Temperatures are likely to go back down to the mid-20s after Tuesday, which is still above average for the time of year, the forecaster said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
32 minutes ago
- The Guardian
Cancer experts alarmed over ‘gut-wrenching' Trump plan to cut research spending by billions
More patients may die as a result of plans drawn up by the Trump administration to cut billions of dollars from the National Cancer Institute (NCI), veteran federal government workers and experts have warned. Nearly $2.7bn would be cut from the agency, which is the largest funder of cancer research in the world – a decline of 37.2% from the previous year – under a budget proposal for 2026, in the latest effort to cut staff and funding. 'These cuts are absolutely gut wrenching,' Erin Lavik, former deputy director and chief technology officer at the NCI's division of cancer prevention, told the Guardian. Lavik was fired along with a swath of probationary workers at the institute in February; put on administrative leave in response to a judge's ruling to halt the firings in March; and then terminated again in April. 'We're not making things more efficient or better,' she said. 'What's being left is sort of the non-impactful iterative work, and we're pruning all of the potential for transformative science.' The American Cancer Society Cancer Action Network has cautioned that the proposed cuts 'will set this nation back dramatically in our ability to reduce death and suffering' and noted that cancer is expected to kill more than 618,000 Americans this year. Julie Nickson, vice-president of Federal Advocacy and Coalitions, said: 'This wouldn't just be a blow to science, it's a blow to families, communities, and our economy. Every day counts in the fight against cancer and with more than 2 million Americans expected to be diagnosed with this horrible disease in 2025 alone, now is not the time to go backwards.' Jennifer R Brown, secretary of the American Society of Hematology and director of the Chronic Lymphocytic Leukemia (CLL) Center of the Division of Hematologic Malignancies at Dana-Farber Cancer Institute, told the Guardian that cuts under Donald Trump have 'already been devastating', with key research halted that can't easily be restarted. 'What the public needs to know is that the science that may not sound so obvious, or that they may not know that much about, is really what drives our cancer treatments and our cancer cures. And so if we cut that, we're going to lose it,' said Brown. Cancer research historically funded by the National Institutes of Health (NIH), which houses the NCI, 'is the basic science that figures out what to target in the cancer cell', she said. 'Then a drug may be developed that may be from an academic, it may be from a pharma company, but the trials are then also run by academics and pharma in collaboration, and academics who are funded by NIH, who do the legwork to figure out how the drug is working in patients. 'Pharma companies take the drug to the finish line. And so if we don't have this basic research, we're not going to be able to identify new targets, and that means we're not going to have new therapies, and ultimately more patients may die.' Brown sees a direct link between NIH-funded academic research and cancer drugs for chronic lymphocytic leukemia that helped patients live longer. 'People who would have died in a few months, lived for years with the first version of this drug,' she said. Hundreds of staff have been terminated from the NCI in recent months, including dozens of communications workers. 'Our website, is used worldwide and is the ground truth for cancer information,' said one fired communications employee at the institute, who requested to remain anonymous. 'Science isn't finished until it's communicated.' Between 28 February and 8 April, more than $180m in NCI grants were cancelled by the Trump administration. Sign up to This Week in Trumpland A deep dive into the policies, controversies and oddities surrounding the Trump administration after newsletter promotion NIH declined to comment, deferring to comments on the budget proposal cuts to the office of management and budget, which did not respond to requests for comment. NIH did not comment on how many employees at the agency remain after several rounds of cuts and layoffs. Lavik said the cuts are likely to threaten large-scale research programs, such as the National Community Oncology Research program, which covers community hospitals all over the US and ensures patients have access to clinical trials, cutting edge cancer care, prevention and screenings. 'I am deeply concerned about the future of these really important clinical trials programs that are really hard to rebuild if you stop them,' she said. 'In the prevention program, there are large scale screening trials, and they have large data sets. We were working really hard on policies to make those data sets more accessible and available to the research community. And we're all gone.' Drastic cuts across federal science funding is causing scientists to consider leaving science and eliminating opportunities for younger scientists to enter training pipelines as undergraduate researchers, graduate researchers and postdocs, according to Lavik. 'The things that are transformative are fundamentally high-risk, high-reward research,' she said. 'We start to move into the clinic, and that's what leads to the new kinds of treatments that don't just help a little bit, but really change the face of how we treat patients, how we prevent cancers, how we treat other conditions. 'You have to be willing to do lots and lots of things that don't work. There are so many ways we should be more efficient about what we do. But to do that, you really need those young scientists, those new people in the field; you need the people who've come into the NIH and the NCI, who are thinking differently about doing things and willing to take those big swings.'
Daily Mail
40 minutes ago
- Daily Mail
BREAKING NEWS David Beckham in hospital with mystery injury as Victoria shares picture of star with arm in sling
David Beckham is in hospital with a mystery injury. The footballer has been pictured bandaged up while recovering in a hospital bed Posting a message to her husband on Instagram on Friday morning, Victoria, 51, wrote: 'Get well soon daddy.' David was pictured smiling as he posed with his arm in a blue sling but there was no indication as to how the injury happened. A second photo showed David with a bracelet which read: 'Get well soon' More to follow
Telegraph
2 hours ago
- Telegraph
Cancer deaths cost UK economy £10bn a year
People dying early from cancer costs the UK economy £10.3 billion a year, according to the most comprehensive analysis of its kind. Researchers from Cancer Research UK calculated the number working years lost to the disease, alongside people's expected economic output in that time. They found that cancer deaths among young adults aged 25 to 49 were having a significant effect on overall economic output, costing £3.2 billion every year. When it comes to cancer type, lung cancer accounts for the biggest overall earning loss to the economy of £1.7 billion a year, with 54,000 total productive years of life lost. Bowel cancer accounts for £1.2 billion, with 39,000 years lost, while brain cancer accounts for £0.75 billion, and 26,000 years, and pancreatic £0.61 billion, and 20,000 years. The figures relate to lost earnings and do not include carer costs for looking after people with cancer or the cost of diagnosing or treating the disease. In an accompanying report, Cancer Research UK said improving cancer survival and catching the disease early could boost economic growth. In his foreword to the study, Ian Walker, the executive director of policy, argued that 'cancer isn't just a health challenge, but also an economic one'. He added: 'Current evidence shows that focusing on prevention and early detection and diagnosis is both the right thing to do for people affected by cancer, and the smart thing to do in economic terms.' Overall, each individual adult cancer death was found to cost an average of £61,000 to the economy. The impact was particularly big if people died when younger, owing to the larger loss in terms of working life. In 2023, some 119,000 years were taken from the future working lives of adults under 50, amounting to £3.2 billion in lost output. In the future, losses could grow even more as cancer cases and deaths are projected to rise, with half a million cases diagnosed every year by 2040. Michelle Mitchell, chief executive of Cancer Research UK, said: 'Cancer has an immeasurable impact on patients and their loved ones. But this report reveals there is also a significant economic cost. 'At a time of tight budgets and overstretched services, the Government can't afford to wait any longer. 'The upcoming national cancer plan is an opportunity to transform cancer survival in England. 'Action to prevent more cancers and diagnose them early will give people more moments with those they love, while relieving pressure on the NHS and building a stronger, healthier economy.' As part of its plan, the charity wants the Government to take further action on smoking, obesity and alcohol, all of which contribute to cancer. It also wants to see earlier diagnosis, including fully rolling out lung screening across England, and prioritising research. Annalisa Belloni, lead economist at the charity, said: 'The Government won't deliver growth without delivering for people affected by cancer. 'Dedicating energy and resources to tackling this disease shouldn't be seen as a cost – it's a necessary investment.'
